Hi,
moomoo ID:NaN
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 08247 BIOSINO BIO-TEC > Detailed Quotes

08247 BIOSINO BIO-TEC

Watchlist
1.270
+0.180+16.51%
Closed  02/01 16:08 CCT
High
1.270
Open
1.270
Turnover
5.08K
Low
1.270
Pre Close
1.090
Volume
4.00K
Market Cap
183.78M
P/E(TTM)
70.56
52wk High
1.890
Shares
144.71M
P/E(Static)
Loss
52wk Low
1.000
Float Cap
81.64M
Bid/Ask %
68.42%
Historical High
6.696
Shs Float
64.29M
Volume Ratio
2.00
Historical Low
0.020
Dividend TTM
--
Div Yield TTM
0.114
P/B
0.79
Dividend LFY
--
Div Yield LFY
8.98%
Turnover Ratio
0.01%
Amplitude
0.00%
Avg Price
1.270
Lot Size
2000
Float Cap
81.64M
Bid/Ask %
68.42%
Historical High
6.696
Shs Float
64.29M
Volume Ratio
2.00
Historical Low
0.020
Dividend TTM
--
P/B
0.79
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
0.00%
Avg Price
1.270
Lot Size
2000
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast

News

Comment

News

Announcement

Company Overview More
Zhongsheng Beikong Biotechnology Co., Ltd. (“Zhongsheng Beikong” or the “Company”) is a leading supplier of in vitro diagnostic (“in vitro diagnosis”) reagents in the People's Republic of China (“China”). The Company and its subsidiaries (collectively, the “Group”) are mainly engaged in the development, production, sale and distribution of in vitro diagnostic reagent products, and provide high-quality and reliable disease detection reagent products for hospitals and other medical institutions. The company's main equity holders have strong backgrounds. The largest shareholder, Beijing Saipu Asset Management Co., Ltd., is a wholly-owned subsidiary of the Institute of Biophysics (“Institute of Biophysics”) of the Chinese Academy of Sciences (“Chinese Academy of Sciences”). The Biophysics Institute is one of the most authoritative research institutes in life sciences in China; Beijing Holdings Co., Ltd. (“Beijing Holdings”), the second largest shareholder, is a company incorporated in Hong Kong, and its shares are listed on the main board of the Stock Exchange (stock code: 0392). Beijing Holdings, along with its subsidiaries, is mainly engaged in natural gas business, beer business, sewage treatment and water business, and solid waste treatment business in China. The Group's brand “Zhongsheng” is famous in the industry. “Zhongsheng” was awarded the “Beijing Famous Brand Product” award in 2002, the “No.1 Brand for User Satisfaction Quality and Reputation in the Chinese Diagnostic Reagent Market” award in 2005, and won the title of “Famous Trademark of Beijing”, which is widely recognized by market users and the medical community. Adopting a marketing model combining direct sales and distributors, the Group has established an efficient, stable marketing network covering more than 600 distributors in more than 30 provinces, municipalities and autonomous regions across the country. The Group's diagnostic reagent products are widely sold in domestic hospitals and medical institutions. In addition, the Group's management includes a number of university professors and PhDs, who have continuously strengthened the Group's overall competitiveness based on the business policy of “putting people first, advocating innovation, quality first, and pursuing perfection, honest labor and legal operation”. Many of these managers have carried out research work in biophysics. Their strong scientific research backgrounds and ambitions have laid a good research foundation for Zhongsheng Beijing Holdings and also helped the long-term development of the Group's business. The Company's H shares have been listed on GEM since February 27, 2006.
CEO： Lebin Wu
Market： GEM
Listing Date： 02/27/2006
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Get Started
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist